Point Biopharma is based in Indianapolis, IN. It has raised $650M in total funding. Latest round: IPO.
Point Biopharma is based in Indianapolis, IN. Point Biopharma has raised $650M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is an IPO announced in July 2021. The round record for Point Biopharma runs through 2021; nothing later has been disclosed. Investors on record include RA Capital Management, Johnson & Johnson Innovation – JJDC, Inc., Surveyor Capital, Farallon Capital Management, BVF Partners, Boxer Capital and 5 others. 11 distinct backers are named across the disclosed rounds.
We update the Point Biopharma record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Indianapolis and their backers are listed below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026